Marketing-authorisation holder · United States
Amneal Pharmaceuticals LLC
58 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
58 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 58
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACEBUTOLOL HYDROCHLORIDE200mg base | 400mg base · Capsule | Acebutolol | United States | Marketed | 1995 |
| ACTIVELLA0.5MG; 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1MG; 0.5MG | 1MG/0.5MG · Tablet | Estradiol, Norethindrone | United States | Marketed | 1998 |
| ALBUTEROL SULFATE2mg base | 4mg base · Tablet | Salbutamol | United States | Marketed | 1989 |
| ALYMSYS100mg/4ml(25mg/ml | 400mg/16ml(25mg/ml · Injectable | Bevacizumab | United States | Marketed | 2022 |
| AMINOCAPROIC ACID1gm | 500mg · Tablet | Aminocaproic acid | United States | Marketed | 2018 |
| AMLODIPINE BENZOATE1mg base/ml · Suspension | Amlodipine benzoate | United States | Not marketed | 2023 |
| ARIPIPRAZOLE1mg/ml · Solution | Aripiprazole | United States | Marketed | 2015 |
| ATROPINE SULFATE1% · Solution/drops | Atropine | United States | Marketed | 2014 |
| BEXAROTENE1% · GEL | Bexarotene | United States | Marketed | 2022 |
| BONCRESA60mg/ml · Injectable | Denosumab | United States | Marketed | 2025 |
| BREKIYA (AUTOINJECTOR)1mg/ml · Solution | Dihydroergotamine | United States | Marketed | 2025 |
| CALCIUM ACETATE667mg · Capsule | Calcium acetate | United States | Marketed | 2008 |
| ELURYNG0.015mg/24hr; 0.12mg/24hr · Ring | Ethinyl estradiol, Etonogestrel | United States | Marketed | 2019 |
| ERYTHROMYCIN250mg | 333mg | 500mg · Tablet, delayed release | Erythromycin | United States | Marketed | 2019 |
| ESTRADIOL10mcg · Tablet | Estradiol | United States | Marketed | 2015 |
| ESTRADIOL AND PROGESTERONE1mg; 100mg · Capsule | Estradiol, Progesterone | United States | Not marketed | 2022 |
| ETODOLAC400mg | 500mg · Tablet | Etodolac | United States | Marketed | 1997 |
| EXENATIDE SYNTHETIC300mcg/1.2ml (250mcg/ml) | 600mcg/2.4ml (250mcg/ml) · Injectable | Exenatide synthetic | United States | Marketed | 2024 |
| IBUPROFEN200mg | 200mg free acid and potassium salt · Capsule | Ibuprofen, Salt | United States | Marketed | 1998 |
| IOHEXOL64.7% · Solution | Iohexol | United States | Marketed | 2025 |
| LIORESAL0.05mg/ml | 0.5mg/ml | 2mg/ml · Injectable | Baclofen | United States | Marketed | 1992 |
| LISDEXAMFETAMINE DIMESYLATE10mg | 20mg | 30mg | 40mg | 50mg | 60mg | 70mg · Capsule | Lisdexamfetamine dimesylate | United States | Marketed | 2023 |
| LOTEPREDNOL ETABONATE0.2% | 0.5% · Suspension/drops | Loteprednol | United States | Marketed | 2019 |
| MEMANTINE HYDROCHLORIDE14mg | 21mg | 28mg | 7mg · Capsule, extended release | Memantine | United States | Marketed | 2016 |
| MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE10mg; 14mg | 10mg; 21mg | 10mg; 28mg | 10mg; 7mg · Capsule, extended release | Donepezil, Memantine | United States | Marketed | 2017 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 58 | 56 | 2 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.